Skip to content
PeptideTech
Cart

Home / Research library / Tesamorelin

Peptides

Tesamorelin: molecular data, studies & sources

Tesamorelin is catalogued here as a research compound. This profile brings together the molecular source record, selected indexed publications and available supplier comparisons. Evidence for a named substance does not authenticate a commercial product.

Compiled by PeptideTech Editors · Sources checked · Selected bibliography, not a systematic review

Molecular formula, weight & structure

Molecular formula (MF)
C221H366N72O67S
Molecular weight (MW)
5136 g/mol
PubChem compound ID
16137828
Record title
Tesamorelin

Values describe the selected PubChem molecular entity. Counterions, salt forms, hydration and sequence changes can alter the supplied material. Confirm the exact identity against the supplier specification.

Source: PubChem CID 16137828 · retrieved 2026-09-21

PubChem 2D molecular structure for Tesamorelin, CID 16137828
2D depiction from PubChem. Open to inspect the full image. This drawing represents the selected record, not a vendor batch test.
Chemical identifiers and source data
IUPAC name
(4S)-4-[[2-[[(2S)-5-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-3-carboxy-2-[[(2S)-2-[[(2S)-2-[[(E)-hex-3-enoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]propanoyl]amino]propanoyl]amino]propanoyl]amino]-3-methylpentanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]-4-oxobutanoyl]amino]-3-hydroxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]hexanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]-5-oxopentanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxypropanoyl]amino]propanoyl]amino]-5-carbamimidamidopentanoyl]amino]hexanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-5-oxopentanoyl]amino]-3-carboxypropanoyl]amino]-3-methylpentanoyl]amino]-4-methylsulfanylbutanoyl]amino]-3-hydroxypropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-oxopentanoyl]amino]-5-oxopentanoyl]amino]acetyl]amino]-5-[[(2S)-1-[[(2S)-4-amino-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-5-oxopentanoic acid
InChIKey
QBEPNUQJQWDYKU-BMGKTWPMSA-N
SMILES
CC/C=C/CC(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N
Machine-readable PubChem source

Human and clinical studies

Selected human-study records are shown with their indexed or reviewed study type. Check the original article for the intervention, formulation and controls; the molecule can also be a comparator or measured variable.

  1. Human study · PubMed trial index

    Efficacy and safety of tesamorelin in people with HIV on integrase inhibitors.

    Russo SC, Ockene MW, Arpante AK et al. · AIDS (London, England) · 2024

    PMID 38905488 · DOI: 10.1097/QAD.0000000000003965

  2. Human study · PubMed trial index

    Safety and metabolic effects of tesamorelin, a growth hormone-releasing factor analogue, in patients with type 2 diabetes: A randomized, placebo-controlled trial.

    Clemmons DR, Miller S, Mamputu JC et al. · PloS one · 2017

    PMID 28617838 · DOI: 10.1371/journal.pone.0179538

  3. Human study · PubMed trial index

    Effects of Tesamorelin on Neurocognitive Impairment in Persons With HIV and Abdominal Obesity.

    Ellis RJ, Vaida F, Hu K et al. · The Journal of infectious diseases · 2025

    PMID 39813152 · DOI: 10.1093/infdis/jiaf012

  4. Human study · PubMed trial index

    Effects of tesamorelin on inflammatory markers in HIV patients with excess abdominal fat: relationship with visceral adipose reduction.

    Stanley TL, Falutz J, Mamputu JC et al. · AIDS (London, England) · 2011

    PMID 21516030 · DOI: 10.1097/QAD.0b013e328347f3f1

Preclinical research, reviews & other publications

Animal studies, laboratory experiments, reviews and other indexed papers answer different questions. A review is secondary evidence; a case report does not estimate how often an outcome occurs.

No additional matching publication was retained. The search links below allow further investigation; they are not evidence that a study exists.

    Tesamorelin supplier sources

    Scientific sources describe molecules and experiments. The commercial links below identify recorded supplier packages. A publication or chemical database entry does not verify the seller, purity, sterility or contents of a lot. Some links are affiliate links; see our disclosure.

    Compare all Tesamorelin sizes, forms and supplier prices →

    SupplierRecorded packagesExample source listing
    American PeptidesUSD10mg Vial · 20mg Vial2 recorded offers10mg Vial · $120.00Checked Sep 21, 2026Supplier listing
    Modified AminosUSD10mg Vial · 20mg Vial2 recorded offers10mg Vial · $59.99Checked Sep 16, 2026Supplier listing
    Blank PeptidesUSD10mg Vial1 recorded offers10mg Vial · $75.00Checked Sep 21, 2026Supplier listing
    Amino ClubUSD10mg Vial1 recorded offers10mg Vial · $69.99Checked Sep 16, 2026Supplier listing
    Nova Peptide SupplyUSD5mg Vial · 10mg Vial · 20mg Vial3 recorded offers5mg Vial · $49.99Checked Sep 16, 2026Supplier listing
    Amino USAUSD10mg Vial · 2mg Vial · 5mg Vial3 recorded offers10mg Vial · $81.00Checked Sep 16, 2026Supplier listing
    Cenexa LabsUSD20mg Vial · 5mg Vial · 10mg Vial3 recorded offers20mg Vial · $129.99Checked Sep 16, 2026Supplier listing
    US Peptide LabsUSD10mg Vial · 10mg Oral spray2 recorded offers10mg Vial · $92.00Checked Sep 16, 2026Supplier listing
    Direct PeptidesUSD10mg Vial1 recorded offers10mg Vial · $79.00Checked Sep 16, 2026Supplier listing
    Nuvion PeptidesCAD10mg Vial1 recorded offers10mg Vial · CA$99.99Checked Sep 21, 2026Supplier listing
    AminoVaultUSD10mg Vial1 recorded offers10mg Vial · $89.25Checked Sep 19, 2026Supplier listing
    PhaseOneAUD10mg Vial1 recorded offers10mg Vial · A$127.99Checked Sep 21, 2026Supplier listing
    BioStacksCAD10mg Vial1 recorded offers10mg Vial · CA$180.00Checked Sep 21, 2026Supplier listing
    AllMyPeptidesGBP5mg Vial · 10mg Vial2 recorded offers5mg Vial · £24.99Recorded out of stock · Checked Sep 17, 2026Supplier listing

    Reference sources & further reading

    The citations above link directly to publication records. Encyclopedia links are background reading and are not used to establish clinical effectiveness.

    Search for additional research

    These links run searches; their results have not been individually reviewed and can include unrelated compounds.

    Research information is not a dosing guide or a recommendation for personal use. Study findings are specific to the formulation, population and methods tested. Read our source and correction policy.

    Related research profiles